These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36549391)

  • 21. Biomimetic carbon monoxide delivery based on hemoglobin vesicles ameliorates acute pancreatitis in mice via the regulation of macrophage and neutrophil activity.
    Taguchi K; Nagao S; Maeda H; Yanagisawa H; Sakai H; Yamasaki K; Wakayama T; Watanabe H; Otagiri M; Maruyama T
    Drug Deliv; 2018 Nov; 25(1):1266-1274. PubMed ID: 29847178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lupeol Counteracts the Proinflammatory Signalling Triggered in Macrophages by 7-Keto-Cholesterol: New Perspectives in the Therapy of Atherosclerosis.
    Saha S; Profumo E; Togna AR; Riganò R; Saso L; Buttari B
    Oxid Med Cell Longev; 2020; 2020():1232816. PubMed ID: 33062133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.
    Boada C; Zinger A; Tsao C; Zhao P; Martinez JO; Hartman K; Naoi T; Sukhoveshin R; Sushnitha M; Molinaro R; Trachtenberg B; Cooke JP; Tasciotti E
    Circ Res; 2020 Jan; 126(1):25-37. PubMed ID: 31647755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization.
    Li H; Feng Y; Zheng X; Jia M; Mei Z; Wang Y; Zhang Z; Zhou M; Li C
    J Control Release; 2022 Jan; 341():16-30. PubMed ID: 34793917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomimetic nanoparticles: U937 cell membranes based core-shell nanosystems for targeted atherosclerosis therapy.
    Shen JW; Li C; Yang MY; Lin JF; Yin MD; Zou JJ; Wu PY; Chen L; Song LX; Shao JW
    Int J Pharm; 2022 Jan; 611():121297. PubMed ID: 34822966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ROS-responsive biomimetic nanoparticles for potential application in targeted anti-atherosclerosis.
    Tang D; Wang Y; Wijaya A; Liu B; Maruf A; Wang J; Xu J; Liao X; Wu W; Wang G
    Regen Biomater; 2021 Aug; 8(4):rbab033. PubMed ID: 34285811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gliclazide alters macrophages polarization state in diabetic atherosclerosis in vitro via blocking AGE-RAGE/TLR4-reactive oxygen species-activated NF-kβ nexus.
    Jahan H; Choudhary MI
    Eur J Pharmacol; 2021 Mar; 894():173874. PubMed ID: 33460615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and Re-polarization.
    Yang Y; Guo L; Wang Z; Liu P; Liu X; Ding J; Zhou W
    Biomaterials; 2021 Jan; 264():120390. PubMed ID: 32980634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarb.
    Liu X; Wu J; Tian R; Su S; Deng S; Meng X
    Biomed Pharmacother; 2020 Sep; 129():110433. PubMed ID: 32768936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization.
    Zhang Q; He J; Xu F; Huang X; Wang Y; Zhang W; Liu J
    Biomater Sci; 2021 Sep; 9(18):6153-6168. PubMed ID: 34346410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory Effects of Quercetin on M1/M2 Macrophage Polarization and Oxidative/Antioxidative Balance.
    Tsai CF; Chen GW; Chen YC; Shen CK; Lu DY; Yang LY; Chen JH; Yeh WL
    Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect.
    Sha X; Dai Y; Chong L; Wei M; Xing M; Zhang C; Li J
    J Nanobiotechnology; 2022 Dec; 20(1):506. PubMed ID: 36456996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioredoxin-1 promotes anti-inflammatory macrophages of the M2 phenotype and antagonizes atherosclerosis.
    El Hadri K; Mahmood DF; Couchie D; Jguirim-Souissi I; Genze F; Diderot V; Syrovets T; Lunov O; Simmet T; Rouis M
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1445-52. PubMed ID: 22516068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facile engineering of resveratrol nanoparticles loaded with 20(S)-protopanaxadiol for the treatment of periodontitis by regulating the macrophage phenotype.
    Huangfu H; Du S; Zhang H; Wang H; Zhang Y; Yang Z; Zhang X; Ren S; Chen S; Wang C; Zhang Y; Zhou Y
    Nanoscale; 2023 May; 15(17):7894-7908. PubMed ID: 37060139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-lethal sonodynamic therapy facilitates the M1-to-M2 transition in advanced atherosclerotic plaques via activating the ROS-AMPK-mTORC1-autophagy pathway.
    Yang Y; Wang J; Guo S; Pourteymour S; Xu Q; Gong J; Huang Z; Shen Z; Diabakte K; Cao Z; Wu G; Natalia S; Tian Z; Jin H; Tian Y
    Redox Biol; 2020 May; 32():101501. PubMed ID: 32179242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet membrane-cloaked selenium/ginsenoside Rb1 nanosystem as biomimetic reactor for atherosclerosis therapy.
    Yin M; Lin J; Yang M; Li C; Wu P; Zou J; Jiang Y; Shao J
    Colloids Surf B Biointerfaces; 2022 Jun; 214():112464. PubMed ID: 35334311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wutou decoction attenuates the synovial inflammation of collagen-induced arthritis rats via regulating macrophage M1/M2 type polarization.
    Lin W; Shen P; Huang Y; Han L; Ba X; Huang Y; Yan J; Li T; Xu L; Qin K; Chen Z; Tu S
    J Ethnopharmacol; 2023 Jan; 301():115802. PubMed ID: 36209953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic Oxygen Generation and Reactive Oxygen Species Scavenging by Manganese Ferrite/Ceria Co-decorated Nanoparticles for Rheumatoid Arthritis Treatment.
    Kim J; Kim HY; Song SY; Go SH; Sohn HS; Baik S; Soh M; Kim K; Kim D; Kim HC; Lee N; Kim BS; Hyeon T
    ACS Nano; 2019 Mar; 13(3):3206-3217. PubMed ID: 30830763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Bivalent Mannosylated Targeting Ligand Displayed on Nanoparticles Selectively Targets Anti-Inflammatory M2 Macrophages.
    Chen P; Zhang X; Venosa A; Lee IH; Myers D; Holloway JA; Prud'homme RK; Gao D; Szekely Z; Laskin JD; Laskin DL; Sinko PJ
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32182675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-CXCR2 antibody-coated nanoparticles with an erythrocyte-platelet hybrid membrane layer for atherosclerosis therapy.
    Huang R; Zhang L; Li X; Liu F; Cheng X; Ran H; Wang Z; Li Y; Feng Y; Liang L; Su W; Melgiri ND; Sun Y
    J Control Release; 2023 Apr; 356():610-622. PubMed ID: 36898531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.